The expression of cohesin subunit SA2 predicts breast cancer survival

Applied Immunohistochemistry and Molecular Morphology

Volumn 24, Issue 9, 2016, Pages 615-621

  Repo, Heli ^a   Löyttyniemi, Eliisa ^b   Nykänen, Marjukka ^c   Lintunen, Minnamaija ^a   Karra, Henna ^d   Pitkänen, Reino ^c   Söderström, Mirva ^a   Kuopio, Teijo ^c   Kronqvist, Pauliina ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^d Central Hospital of Pori   (Finland)

Author keywords

breast cancer; cohesion; DNA content; immunohistochemistry; prognosis

Indexed keywords

COHESIN; COHESIN SUBUNIT SA2; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; NONHISTONE PROTEIN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST CANCER CELL LINE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DNA CONTENT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; OUTCOME ASSESSMENT; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SUBUNIT; SURVIVAL PREDICTION; TUMOR INVASION; BREAST TUMOR; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHROMOSOMAL PROTEINS, NON-HISTONE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 84944342453     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0000000000000240     Document Type: Article

References (40)

1. Sumara I, Vorlaufer E, Gieffers C, et al. Characterization of vertebrate cohesin complexes and their regulation in prophase. J Cell Biol. 2000;151:749-762.
2. Ciosk R, Shirayama M, Shevchenko A, et al. Cohesin's binding to chromosomes depends on a separate complex consisting of Scc2 and Scc4 proteins. Mol Cell. 2000;5:243-254.
3. Hauf S, Waizenegger IC, Peters JM. Cohesin cleavage by separase required for anaphase and cytokinesis in human cells. Science. 2001;293:1320-1323.
4. Nasmyth K, Haering CH. The structure and function of SMC and kleisin complexes. Annu Rev Biochem. 2005;74:595-648.
5. Hauf S, Roitinger E, Koch B, et al. Dissociation of cohesin from chromosome arms and loss of arm cohesion during early mitosis depends on phosphorylation of SA2. PLoS Biol. 2005;3:e69.
6. Sjogren C, Nasmyth K. Sister chromatid cohesion is required for postreplicative double-strand break repair in Saccharomyces cerevisiae. Curr Biol. 2001;11:991-995.
7. Kong X, Ball AR Jr, Pham HX, et al. Distinct functions of human cohesin-SA1 and cohesin-SA2 in double-strand break repair. Mol Cell Biol. 2014;34:685-698.
8. Antony J, Dasgupta T, Rhodes JM, et al. Cohesin modulates transcription of estrogen-responsive genes. Biochim Biophys Acta. 2015;1849:257-269.
9. Bose T, Gerton JL. Cohesinopathies, gene expression, and chromatin organization. J Cell Biol. 2010;189:201-210.
10. Lara-Pezzi E, Pezzi N, Prieto I, et al. Evidence of a transcriptional co-Activator function of cohesin STAG/SA/Scc3. J Biol Chem. 2004;279:6553-6559.
11. Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505:495-501.
12. Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO Classification of Tumours of the Breast. Lyon, France: IARC; 2012.
13. Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009;20:1319-1329.
14. Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736-1747.
15. Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997-4013.
16. Karra H, Repo H, Ahonen I, et al. Cdc20 and securin overexpression predict short-Term breast cancer survival. Br J Cancer. 2014;110:2905-2913.
17. Foster RE, Abdulrahman M, Morris MR, et al. Characterization of a 3;6 translocation associated with renal cell carcinoma. Genes Chromosomes Cancer. 2007;46:311-317.
18. Solomon DA, Kim T, Diaz-Martinez LA, et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science. 2011;333:1039-1043.
19. Xu H, Yan M, Patra J, et al. Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers. Breast Cancer Res. 2011;13:R9.
20. Atienza JM, Roth RB, Rosette C, et al. Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells. Mol Cancer Ther. 2005;4:361-368.
21. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530-536.
22. Xu H, Yan Y, Deb S, et al. Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumors. Cell Rep. 2014;9:1781-1797.
23. Porkka KP, Tammela TL, Vessella RL, et al. RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer. Genes Chromosomes Cancer. 2004;39:1-10.
24. Rocquain J, Gelsi-Boyer V, Adelaide J, et al. Alteration of cohesin genes in myeloid diseases. Am J Hematol. 2010;85:717-719.
25. Yadav S, Sehrawat A, Eroglu Z, et al. Role of SMC1 in overcoming drug resistance in triple negative breast cancer. PLoS One. 2013;8:e64338.
26. Ghiselli G, Iozzo RV. Overexpression of bamacan/SMC3 causes transformation. J Biol Chem. 2000;275:20235-20238.
27. Rae FK, Hooper JD, Nicol DL, et al. Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors. Mol Carcinog. 2001;32:44-53.
28. Xu LL, Shanmugam N, Segawa T, et al. A novel androgenregulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. Genomics. 2000;66:257-263.
29. Giannini G, Ambrosini MI, Di Marcotullio L, et al. EGF-And cellcycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer. Mol Carcinog. 2003;38:188-200.
30. Solomon DA, Kim JS, Bondaruk J, et al. Frequent truncating mutations of STAG2 in bladder cancer. Nat Genet. 2013;45:1428-1430.
31. Solomon DA, Kim JS, Waldman T. Cohesin gene mutations in tumorigenesis: from discovery to clinical significance. BMB Rep. 2014;47:299-310.
32. Thol F, Bollin R, Gehlhaar M, et al. Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications. Blood. 2014;123:914-920.
33. Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059-2074.
34. Gerton JL. Translational mechanisms at work in the cohesinopathies. Nucleus. 2012;3:520-525.
35. Stephens PJ, Tarpey PS, Davies H, et al. The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012;486:400-404.
36. Panigrahi AK, Pati D. Road to the crossroads of life and death: linking sister chromatid cohesion and separation to aneuploidy, apoptosis and cancer. Crit Rev Oncol Hematol. 2009;72: 181-193.
37. Balbas-Martinez C, Sagrera A, Carrillo-de-Santa-Pau E, et al. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet. 2013;45:1464-1469.
38. Zhang N, Jiang Y, Mao Q, et al. Characterization of the interaction between the cohesin subunits Rad21 and SA1/2. PLoS One. 2013;8:e69458.
39. Canudas S, Smith S. Differential regulation of telomere and centromere cohesion by the Scc3 homologues SA1 and SA2, respectively, in human cells. J Cell Biol. 2009;187:165-173.
40. Atalay A, Crook T, Ozturk M, et al. Identification of genes induced by BRCA1 in breast cancer cells. Biochem Biophys Res Commun. 2002;299:839-846.